The Drug List Gap Nobody Talks About
When we talk about MDR1, the conversation almost always orbits the dramatic emergencies — the ivermectin overdose, the loperamide collapse, the dog who doesn’t wake up from sedation. Those are the stories that scare people into testing their dogs, and rightly so.
But there’s a quieter MDR1 issue that affects a huge number of herding breeds every single day, year after year: chronic allergies. Atopic dermatitis — itchy, inflamed, miserable skin disease — is extremely common in Collies, Shelties, Aussies, and their mixes. And one of the mainstay long-term treatments, cyclosporine (sold as Atopica), is a P-glycoprotein substrate that appears on the MDR1 problem drug list.
If your herding dog has lifelong skin allergies, this is a drug you may give every day for years. So the nuance here matters more than almost any single-dose emergency. Let me walk through what’s actually true, because the answer isn’t “avoid it” — it’s “manage it correctly.”
Why Cyclosporine Lands on the List at All
Cyclosporine is a textbook P-glycoprotein substrate. In human transplant medicine it’s one of the classic drugs whose blood levels get pushed around by P-glycoprotein activity. So it makes sense that it shows up on the MDR1 list — the broken pump in an affected dog can change how the drug is handled.
But here’s the crucial distinction. Cyclosporine is not on the list for the same reason loperamide and ivermectin are.
Loperamide and ivermectin are dangerous in MDR1 dogs because they flood the brain and cause acute neurotoxicity — the wobbliness, tremors, and coma. Cyclosporine does not show that dramatic, sudden increased sensitivity. It isn’t a drug that’s going to send your dog into a neurological crisis from one dose. Its place on the list is about monitoring, not avoidance.
What the MDR1 mutation can do with cyclosporine is alter the drug’s pharmacokinetics — how it’s absorbed, distributed, and cleared. An affected dog may run higher blood concentrations of cyclosporine than expected for a given dose. That’s not an emergency. But it does mean the dog could be sitting at an effectively higher dose than intended, which raises the odds of the drug’s ordinary, dose-dependent side effects.
What “Monitoring” Actually Means in Practice
Because an MDR1 dog may hold higher cyclosporine levels, the standard advice is therapeutic drug monitoring — blood tests that measure the actual cyclosporine concentration rather than assuming the labeled dose lands where it should.
This lets your vet do two things: confirm the drug is in the effective range (so you’re not under-treating a miserable, itchy dog), and confirm it isn’t sitting too high (so you’re not provoking avoidable side effects). For a normal/normal dog, vets often dose Atopica by the label and adjust by response. For a known MDR1-affected dog on long-term cyclosporine, asking about blood-level monitoring is a reasonable, proactive conversation.
The side effects to watch for are dose-related and worth knowing, because they’re your early warning that levels may be running high:
- Gastrointestinal upset — vomiting and diarrhea, especially in the first weeks
- Gingival hyperplasia (overgrowth of the gums)
- Papillomas or other skin growths
- Increased susceptibility to infection, since cyclosporine is an immunosuppressant
None of these are reasons to panic, and most resolve with dose adjustment. But in an MDR1 dog they’re worth flagging earlier rather than later.
The Interaction Trap: Cyclosporine Cuts Both Ways
Here’s a subtlety that even some vets overlook, and it’s important if your herding dog takes more than one medication.
Cyclosporine isn’t only a P-glycoprotein substrate — it’s also a P-glycoprotein inhibitor. That means while it’s in your dog’s system, it can suppress whatever pump activity remains and raise the blood levels of other P-glycoprotein-substrate drugs given at the same time.
In a normal dog, that residual pump matters. In an MDR1 normal/mutant dog, you’re stacking a partial genetic deficit on top of a drug that further blocks the pump. So the combination of cyclosporine plus another substrate drug deserves a careful look. Always make sure every vet treating your dog knows it’s on Atopica before they add anything new — this is exactly the kind of detail a vet visit checklist is designed to capture.
Where Apoquel and Cytopoint Fit
The good news for itchy herding breeds is that cyclosporine is no longer the only game in town. Two newer atopic-dermatitis treatments are far less complicated from an MDR1 standpoint.
Cytopoint (lokivetmab) is a biologic — a monoclonal antibody that targets IL-31, one of the proteins driving the itch signal. Antibodies are large molecules that don’t cross the blood-brain barrier and aren’t P-glycoprotein substrates. From an MDR1 perspective, Cytopoint is about as clean as a drug gets, which makes it an attractive first-line option for many affected dogs. It’s given as an injection every four to eight weeks.
Apoquel (oclacitinib) is a JAK inhibitor that blocks itch and inflammation signaling. It is not a significant P-glycoprotein concern and is generally considered safe for MDR1 dogs. It works fast, which families managing acute flare-ups appreciate.
Plain old antihistamines (like diphenhydramine) and short courses of steroids (like prednisone) are likewise not MDR1 issues — they don’t depend on P-glycoprotein in a way the mutation disrupts.
So the chronic-allergy toolkit for an MDR1 herding breed is broad. Cyclosporine remains a powerful, legitimate option — many dogs do beautifully on it — but if you’d rather sidestep the monitoring and interaction questions entirely, Cytopoint and Apoquel give you genuinely MDR1-friendly alternatives to discuss.
What to Actually Do
If your herding dog has chronic skin allergies and MDR1 is in the picture, here’s the short version:
- Know the genotype. It changes how cautiously cyclosporine should be dosed and monitored.
- If your dog goes on Atopica long-term, ask your vet about therapeutic drug monitoring and watch for the dose-related side effects above.
- Tell every vet your dog is on cyclosporine before any new drug is added — it can raise the levels of other substrate medications.
- Ask about Cytopoint and Apoquel as MDR1-friendly alternatives if you’d prefer fewer moving parts.
Chronic care is a marathon, not a single dramatic moment — but it’s exactly the kind of long-haul management where knowing your dog’s genotype quietly pays off, week after week. For more on managing medications safely over a lifetime, see our resources on safe medications and the broader MDR1 topic.
Managing a herding breed’s lifelong allergies and not sure how MDR1 fits in? Contact us — chronic-care questions like this are some of the most common ones our community helps each other navigate.